Enhanced sensitivity to cholera toxin in female ADP-ribosylarginine hydrolase (ARH1)-deficient mice

• Kizuku Watanabe,

  Roles Writing – original draft

  Affiliation Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Jiro Kato,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Jianfeng Zhu,

  Roles Formal analysis, Investigation, Methodology

  Affiliations Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America, Present address: Siemens Healthcare Diagnostics Inc., Newark, Delaware, United States of America

  ⨯
• Hirotake Oda,

  Roles Investigation

  Affiliation Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Hiroko Ishiwata-Endo,

  Roles Investigation, Methodology

  Affiliation Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Joel Moss

  Roles Supervision, Writing – original draft, Writing – review & editing

  * E-mail: mossj@nhlbi.nih.gov

  Affiliation Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯